Nonetheless, the correlation of MT1-MMP up-regulation with patients with metastatic breast cancer, and the inverse correlation of high MT1-MMP expression with patient survival time [8], strongly indicates application of selective MT1-MMP inhibitors in breast cancer. Here, MMP14 is linked to breast cancer.